...
首页> 外文期刊>Japanese Journal of Cancer Research >Rare-type mutations of MMAC1 tumor suppressor gene in human glioma cell lines and their tumors of origin.
【24h】

Rare-type mutations of MMAC1 tumor suppressor gene in human glioma cell lines and their tumors of origin.

机译:人胶质瘤细胞系及其起源肿瘤中MMAC1抑癌基因的罕见突变。

获取原文
获取原文并翻译 | 示例

摘要

A total of 10 glioma cell lines were examined to evaluate the status of the MMAC1 gene, a candidate tumor suppressor gene. Six cell lines showed mutations with presumed loss of heterozygosity and 1 cell line showed no mRNA expression. The 6 mutations consisted of 3 3-bp deletions (codons 17, 101 or 199), 1 missense mutation (codon 252) and 2 truncation mutations (1 nonsense mutation at codon 233 and 12-bp insertion at codon 241). Among them, the 3-bp deletions, which are a rare type of mutation in MMAC1 gene, were located in the N-terminal half (codons 1-212) of the coding region, which is considered important in MMAC1 function. The missense mutation was located unusually in the C-terminal half (codons 212-403), but it was in a small region in which some other reported missense mutations are clustered. Thus, these 4 mutations were suggested to have functional effects on the MMAC1 activity, like the other 2 mutations with predicted protein truncations. By sequence analysis of cDNA clones, we confirmed that all the mutations including these 4 rare ones were in the MMAC1 gene, not in the PTH2 pseudogene. In 2 cases, we also examined the primary glioma tissues from which the cell lines had been derived and found the same mutations as in the cell lines in both cases. This suggested that the mutations in these cell lines were derived from the primary glioma tissues, but not from artifacts arising during long-term in vitro cultivation.
机译:总共检查了10个神经胶质瘤细胞系,以评估候选肿瘤抑制基因MMAC1基因的状态。 6个细胞系显示突变,推测具有杂合性丧失,1个细胞系未显示mRNA表达。这6个突变包括3个3 bp缺失(第17、101或199个密码子),1个错义突变(第252个密码子)和2个截短突变(第233个密码子无义突变和第241个密码子插入12bp)。其中,3-bp缺失是MMAC1基因中罕见的突变类型,位于编码区的N末端一半(密码子1-212),这被认为对MMAC1功能很重要。错义突变异常地位于C末端的一半(密码子212-403),但是它位于一个很小的区域,在该区域中,其他一些报道的错义突变被聚集。因此,建议这4个突变对MMAC1活性具有功能作用,就像其他2个具有预测蛋白截短的突变一样。通过对cDNA克隆的序列分析,我们确认了包括这4个罕见突变在内的所有突变均在MMAC1基因中,而不在PTH2假基因中。在2例病例中,我们还检查了衍生细胞系的原发性神经胶质瘤组织,发现这两种情况下的突变与细胞系相同。这表明这些细胞系中的突变源自原发性神经胶质瘤组织,而不源自长期体外培养期间产生的假象。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号